Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02400658 · ClinicalTrials.gov registry record · NA
Efficacy of IORT With CT-Guided HDR Brachytherapy for Treatment of Breast Cancer
A NA study of Breast Cancer, sponsored by Shayna Showalter, MD.
- Active
- Registry status
- NA
- Development phase
- 358
- Enrollment target
- 3
- Study locations
NCT02400658: Active NA study of Breast Cancer, sponsored by Shayna Showalter, MD.
NCT02400658 is a NA study of Breast Cancer that is active but no longer recruiting, run by Shayna Showalter, MD. The registered enrollment target is 358 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (87% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02400658, a NA study of Breast Cancer, is active but no longer recruiting, sponsored by Shayna Showalter, MD.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 358 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to evaluate an investigational way to provide radiation therapy to treat early-stage breast cancer at the time of surgery.
Conditions Studied
Interventions
- DEVICE IORT with CT-Guided HDR Brachytherapy
Study Locations (3)
New Jersey
- Hackensack Meridian Health - John Theurer Cancer Center - Hackensack
Pennsylvania
- Thomas Jefferson University - Philadelphia
Virginia
- University of Virginia - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 358 participants |
| Start Date | 2015-03 |
| Est. Completion | 2027-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02400658
The ClinicalTrials.gov registry entry for NCT02400658 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 358 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (87% lower). The listed sponsor is Shayna Showalter, MD, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which IORT with CT-Guided HDR Brachytherapy is the first listed.
NCT02400658 reports 3 study locations spanning 3 distinct geographic areas - top geographies include New Jersey, Pennsylvania, Virginia.
Frequently Asked Questions
What is clinical trial NCT02400658 about?
NCT02400658 is a clinical study titled "Efficacy of IORT With CT-Guided HDR Brachytherapy for Treatment of Breast Cancer". The purpose of this study is to evaluate an investigational way to provide radiation therapy to treat early-stage breast cancer at the time of surgery.
What is the current status of trial NCT02400658?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 358 participants. The study started on 2015-03. Estimated completion is 2027-09.
What conditions does trial NCT02400658 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT02400658?
The interventions under investigation include: IORT with CT-Guided HDR Brachytherapy (DEVICE).
Who is sponsoring clinical trial NCT02400658?
This trial is sponsored by Shayna Showalter, MD, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02400658 being conducted?
This trial has 3 study locations across New Jersey, Pennsylvania, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.